Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
europe
health
life sciences
medicine
20/20 healthcare partners
america
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
artificial intelligence
biology
biotechnology
boston
boston blog main
boston top stories
cambridge
christian angermayer
chronic pain
coronavirus
covid-19
disease
dolby family ventures
drug discovery
enclear therapies
financing
funding
fundings & exits
genomics
gf securities
global health sciences fund
health/life sciences
hillel bachrach
hydroxychloroquine
jason camm
karimah es sabar
khosla ventures
labcentral
medical device
mogrify
What
raised
4
×
therapies
4
×
based
health
market
million
new
working
ago
areas
associated
billion
biotech
cambridge
cell
closed
companies
company
costs
covid
date
develop
development
device
dialysis
discouraging
disease
diseases
disorders
drugs
enclear
ending
europe
february
financing
follows
founded
harmful
healthcare
hydroxychloroquine
Language
unset
Current search:
therapies
×
raised
×
@geekwire.com
3 years ago
WHO resumes using hydroxychloroquine in COVID trial; questions raised about discouraging study
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@techcrunch.com
4 years ago
UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon
@techcrunch.com
5 years ago
Tackling the $190 billion physical therapy market, Sword Health raises $8 million from Khosla Ventures
